Cargando…
Dopamine: an immune transmitter
The dopaminergic system controls several vital central nervous system functions, including the control of movement, reward behaviors and cognition. Alterations of dopaminergic signaling are involved in the pathogenesis of neurodegenerative and psychiatric disorders, in particular Parkinson’s disease...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749467/ https://www.ncbi.nlm.nih.gov/pubmed/32594028 http://dx.doi.org/10.4103/1673-5374.284976 |
_version_ | 1783625309271097344 |
---|---|
author | Thomas Broome, Sarah Louangaphay, Krystal Keay, Kevin A. Leggio, Gian Marco Musumeci, Giuseppe Castorina, Alessandro |
author_facet | Thomas Broome, Sarah Louangaphay, Krystal Keay, Kevin A. Leggio, Gian Marco Musumeci, Giuseppe Castorina, Alessandro |
author_sort | Thomas Broome, Sarah |
collection | PubMed |
description | The dopaminergic system controls several vital central nervous system functions, including the control of movement, reward behaviors and cognition. Alterations of dopaminergic signaling are involved in the pathogenesis of neurodegenerative and psychiatric disorders, in particular Parkinson’s disease, which are associated with a subtle and chronic inflammatory response. A substantial body of evidence has demonstrated the non-neuronal expression of dopamine, its receptors and of the machinery that governs synthesis, secretion and storage of dopamine across several immune cell types. This review aims to summarize current knowledge on the role and expression of dopamine in immune cells. One of the goals is to decipher the complex mechanisms through which these cell types respond to dopamine, in order to address the impact this has on neurodegenerative and psychiatric pathologies such as Parkinson’s disease. A further aim is to illustrate the gaps in our understanding of the physiological roles of dopamine to encourage more targeted research focused on understanding the consequences of aberrant dopamine production on immune regulation. These highlights may prompt scientists in the field to consider alternative functions of this important neurotransmitter when targeting neuroinflammatory/neurodegenerative pathologies. |
format | Online Article Text |
id | pubmed-7749467 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-77494672020-12-21 Dopamine: an immune transmitter Thomas Broome, Sarah Louangaphay, Krystal Keay, Kevin A. Leggio, Gian Marco Musumeci, Giuseppe Castorina, Alessandro Neural Regen Res Review The dopaminergic system controls several vital central nervous system functions, including the control of movement, reward behaviors and cognition. Alterations of dopaminergic signaling are involved in the pathogenesis of neurodegenerative and psychiatric disorders, in particular Parkinson’s disease, which are associated with a subtle and chronic inflammatory response. A substantial body of evidence has demonstrated the non-neuronal expression of dopamine, its receptors and of the machinery that governs synthesis, secretion and storage of dopamine across several immune cell types. This review aims to summarize current knowledge on the role and expression of dopamine in immune cells. One of the goals is to decipher the complex mechanisms through which these cell types respond to dopamine, in order to address the impact this has on neurodegenerative and psychiatric pathologies such as Parkinson’s disease. A further aim is to illustrate the gaps in our understanding of the physiological roles of dopamine to encourage more targeted research focused on understanding the consequences of aberrant dopamine production on immune regulation. These highlights may prompt scientists in the field to consider alternative functions of this important neurotransmitter when targeting neuroinflammatory/neurodegenerative pathologies. Wolters Kluwer - Medknow 2020-06-19 /pmc/articles/PMC7749467/ /pubmed/32594028 http://dx.doi.org/10.4103/1673-5374.284976 Text en Copyright: © 2020 Neural Regeneration Research http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Review Thomas Broome, Sarah Louangaphay, Krystal Keay, Kevin A. Leggio, Gian Marco Musumeci, Giuseppe Castorina, Alessandro Dopamine: an immune transmitter |
title | Dopamine: an immune transmitter |
title_full | Dopamine: an immune transmitter |
title_fullStr | Dopamine: an immune transmitter |
title_full_unstemmed | Dopamine: an immune transmitter |
title_short | Dopamine: an immune transmitter |
title_sort | dopamine: an immune transmitter |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749467/ https://www.ncbi.nlm.nih.gov/pubmed/32594028 http://dx.doi.org/10.4103/1673-5374.284976 |
work_keys_str_mv | AT thomasbroomesarah dopamineanimmunetransmitter AT louangaphaykrystal dopamineanimmunetransmitter AT keaykevina dopamineanimmunetransmitter AT leggiogianmarco dopamineanimmunetransmitter AT musumecigiuseppe dopamineanimmunetransmitter AT castorinaalessandro dopamineanimmunetransmitter |